Lawrence N. Shulman, MD
Chief of Staff, Senior Vice President for Medical Affairs
Director, Center for Global Cancer Medicine
Dana-Farber Cancer Institute
Harvard Medical School
2013-2014 BCRF Project:
Bringing life-saving cancer care to patients in the developing world is a large unmet need, and every year, many lives are lost unnecessarily. Accurate and timely pathology services are a critical component of providing effective cancer care, determining both diagnosis and optimal treatment. This is particularly true for breast cancer, one of the leading causes of cancer death in the developing world. This project supports the development of pathology capacity in Rwanda, and assesses its quality and timeliness at a facility providing national referral pathology services, and can service as a road map for others to develop pathology capacity in other resource-limited settings.
Lawrence N. Shulman, MD, is Chief of Staff, Senior Vice-President for Medical Affairs, and Chief, Division of General Oncology, Department of Medical Oncology, at Dana-Farber Cancer Institute in Boston, MA. He is also Director of their Center for Global Cancer Medicine, and Director of the Department of Regional Strategy and Development.
Dr. Shulman serves as one of the leaders of the DFCI strategic planning initiative. As Director of the Department of Regional Strategy and Development, he oversees DFCI ambulatory oncology units at regional sites throughout New England. He is also physician leader for the development of clinical information systems for DFCI. He is former Chair of the American Society of Clinical Oncology’s (ASCO) Quality of Care Committee and a member of ASCO’s Health Information Technology Workgroup. He is a member of the Commission on Cancer of the American College of Surgeons, and Chair of their Quality Integration Committee.
A specialist in the treatment of patients with breast cancer, his research includes development of new cancer therapies.
He works closely with Partners In Health, where he is Senior Oncology Advisor, helping to lead the development of structured cancer programs for their healthcare sites in Rwanda, Malawi and Haiti.